Studies have confirmed that NAT10 and its associated ac4C modification are highly expressed in various tumors; promote the proliferation, metastasis, drug resistance and immunosuppression of tumor cells; and are closely related to the poor prognosis of patients [17–19]. The gene discussed is NAT10; the disease is neoplasm.